Document Detail


Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels.
MedLine Citation:
PMID:  24314937     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
INTRODUCTION: The metabolic syndrome (MS) components, such as dyslipidemia, prothrombotic status, and increased blood pressure, are risk factors for patients with renal disease. Visceral fat mass is closely related to the MS and atherosclerosis. We investigated the effects of body compositions and MS on anemia parameters and recombinant human erythropoietin (rHuEPO) requirements in maintenance hemodialysis patients.
METHODS: Body composition (body mass index and bioimpedance analysis) and laboratory data were obtained from 110 dialysis patients. The MS was identified according to ATP-III criteria. Anemia parameters, hemoglobin (Hgb), albumin, C-reactive protein (CRP), calcium, phosphorus, parathormone levels, and rHuEPO requirements over the last 6 months were retrospectively analyzed.
RESULTS: Patients with the MS seem to reach target Hgb levels more frequently (10-12 g/dL; 66.3% vs 84.8%; P = .03) without any difference in total intravenous iron therapy dosage. MS patients also required lower rHuEPO for reaching similar Hgb levels compared with patients without MS (2679.3 ± 1936.1 vs 3702.5 ± 2213.0 U/kg/6 mo; P = .02). There were no differences in serum CRP, albumin, or Hgb levels between the 2 groups (P > .05). We observed that patients with MS had significantly higher fat mass and visceral fat ratio, but similar muscle mass values compared with no-MS counterparts (P = .0001 and .001, respectively). However, when we compared the ratios of these parameters we observed a significant reduction in muscle ratios and a significant increase in fat ratios of MS patients (P = .0001).
CONCLUSION: Our results indicate that MS might be an advantage for reaching higher Hgb levels with lower rHuEPO dosages. The possible reason for this might be the good nutritional state and increased fat mass of patients with MS.
Authors:
M E Uyar; E Tutal; Z Bal; S Sezer
Related Documents :
6605367 - Effects of energy delivery via a his bundle catheter during closed chest ablation of th...
6160507 - Autodecremental pacing--a microprocessor based modality for the termination of paroxysm...
23851057 - Specificity of electrocardiographic criteria for the differential diagnosis of wide qrs...
7867277 - Ultrasound demonstration of lymph nodes in the hepatoduodenal ligament ('daisy chain no...
8708057 - Nasopharyngeal carcinoma with intracranial spread: ct and mr characteristics.
1593347 - Neurologic events after partial exchange transfusion for priapism in sickle cell disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  45     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3481-4     Citation Subset:  IM    
Copyright Information:
Copyright © 2013. Published by Elsevier Inc.
Affiliation:
Department of Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The prevalence and types of cardiovascular d?sease in pat?ents with end-stage renal d?sease undergoi...
Next Document:  Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of hemod...